EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species
EnhancerAtlas 2.0
TagContent
EnhancerAtlas ID
HS091-24554 
Organism
Homo sapiens 
Tissue/cell
HepG2 
Coordinate
chr19:50009130-50010530 
Target genes
Number: 40             
NameEnsembl ID
RPL18ENSG00000063177
PPP1R15AENSG00000087074
NUCB1ENSG00000104805
BAXENSG00000087088
FTLENSG00000087086
RUVBL2ENSG00000183207
SNRNP70ENSG00000104852
LIN7BENSG00000104863
C19orf73ENSG00000221916
PPFIA3ENSG00000177380
HRCENSG00000130528
TRPM4ENSG00000130529
AC011450.2ENSG00000235555
SLC6A16ENSG00000063127
CD37ENSG00000104894
AC011450.1ENSG00000197813
TEAD2ENSG00000074219
DKKL1ENSG00000104901
SLC17A7ENSG00000104888
PIH1D1ENSG00000104872
ALDH16A1ENSG00000161618
FLT3LGENSG00000090554
RPL13AENSG00000142541
SNORD33ENSG00000199631
RPS11ENSG00000142534
SNORD35BENSG00000200530
FCGRTENSG00000104870
RCN3ENSG00000142552
PRR12ENSG00000126464
SCAF1ENSG00000126461
IRF3ENSG00000126456
PRMT1ENSG00000126457
C19orf76ENSG00000224420
CPT1CENSG00000169169
CTBENSG00000243829
AP2A1ENSG00000196961
MED25ENSG00000104973
PTOV1ENSG00000104960
TBC1D17ENSG00000104946
AKT1S1ENSG00000204673
TF binding sites/motifs
Number: 13             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
CTCFMA0139.1chr19:50010002-50010021AGGTCAGTAGGGGGCACTA+6.23
Foxd3MA0041.1chr19:50009253-50009265GTTTGTTTGTTT+6.32
ZNF263MA0528.1chr19:50010300-50010321CTTCCCCTTCCCCTCTCCTCT-6.04
ZNF263MA0528.1chr19:50010283-50010304TTCTCCTTCCCCTCCCCCTTC-6.09
ZNF263MA0528.1chr19:50010293-50010314CCTCCCCCTTCCCCTTCCCCT-6.19
ZNF263MA0528.1chr19:50010275-50010296CCTTCCCCTTCTCCTTCCCCT-6.2
ZNF263MA0528.1chr19:50010287-50010308CCTTCCCCTCCCCCTTCCCCT-6.37
ZNF263MA0528.1chr19:50010274-50010295CCCTTCCCCTTCTCCTTCCCC-6.51
ZNF263MA0528.1chr19:50010268-50010289TCCTTTCCCTTCCCCTTCTCC-6.62
ZNF263MA0528.1chr19:50010286-50010307TCCTTCCCCTCCCCCTTCCCC-6.97
ZNF263MA0528.1chr19:50010292-50010313CCCTCCCCCTTCCCCTTCCCC-6.98
ZNF263MA0528.1chr19:50010271-50010292TTTCCCTTCCCCTTCTCCTTC-7.36
ZNF263MA0528.1chr19:50010280-50010301CCCTTCTCCTTCCCCTCCCCC-8.01
Number of super-enhancer constituents: 19             
IDCoordinateTissue/cell
SE_68187chr19:49976788-50037595TC32
SE_68188chr19:49976788-50037595TC32
SE_68189chr19:49976788-50037595TC32
SE_68190chr19:49976788-50037595TC32
SE_68191chr19:49976788-50037595TC32
SE_68192chr19:49976788-50037595TC32
SE_68193chr19:49976788-50037595TC32
SE_68194chr19:49976788-50037595TC32
SE_68464chr19:49990162-50019336TC71
SE_68465chr19:49990162-50019336TC71
SE_68466chr19:49990162-50019336TC71
SE_68467chr19:49990162-50019336TC71
SE_68468chr19:49990162-50019336TC71
SE_68469chr19:49990162-50019336TC71
SE_68470chr19:49990162-50019336TC71
SE_68471chr19:49990162-50019336TC71
SE_68472chr19:49990162-50019336TC71
SE_68473chr19:49990162-50019336TC71
SE_68474chr19:49990162-50019336TC71
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 3             
ChromosomeStartEnd
chr195001036250010419
chr195001016250010372
chr195000984850010361
Number: 1             
IDChromosomeStartEnd
GH19I049506chr195000979350010480
Enhancer Sequence
TTGCAGTGAG CCGAGATCGC ACCACTGCAC TCCAGCCTGG GTGACAGACA GAGACTCCGT 60
CTCAAAAAAA AAAAAAAAAA AGAAATAGGT TGGTGCAAAA GCAATTGTGG TTTTTTGTTT 120
GTTGTTTGTT TGTTTTTGAG TCTCACTCTG TTGCCCAGGC TGGAGTGCAG TGGCACAATC 180
TCATCTCACT GCAACCTCTG CCTCCCAGGT TCAAGCGATT CTCCTGCCTC ACCCTCCCAA 240
GTAGCTGAGA TTACAGGTGC CCACTACCAT GTCTGGCTAA TTTTTGTATT TGTAATAGAG 300
ATGGGGTTTT GCCATGTTGG CCAGGCTGGT CTCAAACTCC CGACCTCAGC CTCCCAAAGT 360
GCTGGGATTA CAGGCGTGAG CCACCGTGTC TAGCCAGCAA TTGCGGGTTT TTTGTTTGTT 420
GGTTTTTTTC AGATGGAGTC TTGCTCTGTC ACCCAGACTG AAGTGCAGTG GCACAATCTC 480
GGCTCATTGT AACTTCCGCC TCCCAGGTTC AAGCGATTCT CCTGCCTCAG CCTCCCAAGT 540
AGCTGGGACT ATTCAGCGAG TGCCACCATG CCTGGCTAAT TTTTGTATTT TTAGTAGAGA 600
CAGGGTTTCA CCATGTTGGC CAGGCTGGTC TGGAACTCCT GACCTCGTGA TCCGTCTGCC 660
TCGGCCTTCC AAAGTGCTGG GATTATAGGC GTGAGCCACC GTGCCCGGCC TGCAATTGGG 720
GTTTTAATGG CAGAAACCGC AATTACTTTT GCACCACCCT AATATAAAGA CACAATTATT 780
ATCCCCATTT TCCAGATAAA GAACCTTTGG CTGGGAGAGG TGTACCTGGA AGAGTCGTGT 840
TTTGGTTTTG AACTCAGGTG TGATTGCCCC CCAGGTCAGT AGGGGGCACT ATTGTGTAAG 900
GGTGGAGAGG AGGGGCAGCG GTTAGGTGGT TCAGGGTGCA CAGCTCAAAG CTGCCTGGGG 960
CCATTCTAGG CACAGAGGCA GGGGCCAGGG CCGGCTTTAA GGCCAGCTCC TCGTGCAGTC 1020
TGAGGAGTGG ATCAGAAGGG ACCAGCACCT GGTGAGTGCT CTACTTGAAC CATCTTGAAA 1080
CTGGAACCAA GGGGACCACA TTTTTGTTTT ATGCTGAGTG TGTCCTGCCA TGGGCTTTTC 1140
CTTTCCCTTC CCCTTCTCCT TCCCCTCCCC CTTCCCCTTC CCCTCTCCTC TTCTCTTCTC 1200
TTCCGTTTTT TGGAGACGGA GTCTTGCTCT GTCGCCCAGG CTGGAGTTCA ATAGCGCAAT 1260
CTCGGCTTAC TGCAACCTCC GCCTCCTGGG TTCGAGTGAT TCTCCTGCCT CAGCCTCCCG 1320
AGTAGCTGGG ATTACAGGTG CGCACTACCA CGTCCGGCTA ATTTTTGTAT TTCTAGTAGA 1380
GACGGGGTTT CACCACGTTG 1400